Superworth

Microbot Medical price to book ratio MBOT

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
0.9×
10-year median
2.8×
Against its 10-year history
1st
percentile: 0 is its lowest day, 100 its highest
10-year range
0.9× to 99.5×
Peer median
2.5×

Microbot Medical's price to book ratio is 0.9× as of Oct 23, 2026.

That is below its ten-year median of 2.8×, lower than on 99% of days in the last ten years.

Over that time it ranged from 0.9× in Nov 2018 to 99.5× in Mar 2017.

The median for 9 medical instruments and supplies stocks of a similar size is 2.5×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.9×0.9×2.3×
20251.8×1.6×25.7×
20244.9×1.8×4.9×
20232.6×1.2×5.8×
20224.3×2.0×6.4×
20213.0×1.9×3.0×
20201.8×1.3×8.9×
20197.5×0.9×25.8×
20180.9×0.9×4.3×
20173.5×2.9×99.5×
20164.0×4.0×6.0×
20156.4×2.7×12.2×
20144.1×4.1×24.2×
201319.8×4.5×19.8×
20126.2×0.8×23.7×
20110.8×0.8×2.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Microbot Medical's size, closest first, today.

CompanyPrice to book ratio
MBOTMicrobot Medical0.9×
APTAlpha Pro Tech0.9×
KEQUKewaunee Scientific1.3×
NEPHNephros3.2×
PDEXPro DEX4.2×
UTMDUtah Medical Products1.9×
INFUInfuSystem4.7×
EMBCEmbectan/m
TCMDTactile Systems Technology2.4×
MDXGMimedx2.6×
Peer median2.5×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Microbot Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.